C096-0401 Screening compound: N-[3-(2-ethylpiperidin-1-yl)propyl]-2-[6-methyl-5-(morpholine-4-sulfonyl)-4-oxo-3H,4H-thieno[2,3-d]pyrimidin-3-yl]acetamide

C096-0401 Screening compound: N-[3-(2-ethylpiperidin-1-yl)propyl]-2-[6-methyl-5-(morpholine-4-sulfonyl)-4-oxo-3H,4H-thieno[2,3-d]pyrimidin-3-yl]acetamide
C096-0401 Screening compound: N-[3-(2-ethylpiperidin-1-yl)propyl]-2-[6-methyl-5-(morpholine-4-sulfonyl)-4-oxo-3H,4H-thieno[2,3-d]pyrimidin-3-yl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C096-0401
N-[3-(2-ethylpiperidin-1-yl)propyl]-2-[6-methyl-5-(morpholine-4-sulfonyl)-4-oxo-3H,4H-thieno[2,3-d]pyrimidin-3-yl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C096-0401

Molecular Formula

C23H35N5O5S2 (C23 H35 N5 O5 S2)

Compound Name

N-[3-(2-ethylpiperidin-1-yl)propyl]-2-[6-methyl-5-(morpholine-4-sulfonyl)-4-oxo-3H,4H-thieno[2,3-d]pyrimidin-3-yl]acetamide

IUPAC name

N-[3-(2-ethylpiperidin-1-yl)propyl]-2-[6-methyl-5-(morpholine-4-sulfonyl)-4-oxo-3H4H-thieno[23-d]pyrimidin-3-yl]acetamide

SMILES

CCC1N(CCCNC(CN(C=Nc2c3c(S(N4CCOCC4)(=O)=O)c(C)s2)C3=O)=O)CCCC1

InChI

InChI=1S/C23H35N5O5S2/c1-3-18-7-4-5-9-26(18)10-6-8-24-19(29)15-27-16-25-22-20(23(27)30)21(17(2)34-22)35(31,32)28-11-13-33-14-12-28/h16,18H,3-15H2,1-2H3,(H,24,29)/t18-/m0/s1

InChI Key

XXXLQICJLQHRCG-SFHVURJKSA-N

MDL Number (MFCD)

MFCD14719369

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

525.69

Hydrogen Bond Acceptors Count

12.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

0.645

Distribution Coefficient, logD

-2.280

Water Solubility, LogSw

-1.79

Polar Surface Area

93.968

Acid Dissociation Constant (pKa)

15.94

Base Dissociation Constant (pKb)

10.32

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

69.60

C096-0401 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with C096-0401 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C096-0401?
Check Price and Availability of C096-0401, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C096-0401 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C096-0401
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C096-0401
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C096-0401 available by request